28th week of 2019 patent applcation highlights part 10 |
Patent application number | Title | Published |
20190209603 | MODULATION OF PCSK9 AND LDLR THROUGH DRP1 INHIBITION | 2019-07-11 |
20190209604 | OLIGONUCLEOTIDES, COMPOSITIONS AND METHODS THEREOF | 2019-07-11 |
20190209605 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | 2019-07-11 |
20190209606 | SITU GELLING COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION AND TISSUE DAMAGE | 2019-07-11 |
20190209607 | COMPOSITIONS FOR TREATING ACID-BASE DISORDERS | 2019-07-11 |
20190209608 | DRINKING WATER COMPOSITION FOR IMPROVING METABOLISM | 2019-07-11 |
20190209609 | METHODS AND COMPOUNDS FOR PH CONTROLLED ANTICOAGULANT USING PHOSPHATES | 2019-07-11 |
20190209610 | INDUCED PLURIPOTENT STEM CELLS PRODUCED FROM DENDRITIC CELLS | 2019-07-11 |
20190209611 | Chimeric antigen receptor specific for tumor cells | 2019-07-11 |
20190209612 | Method | 2019-07-11 |
20190209613 | Novel Method for Identifying DeltaT-Cell (or GammaT-Cell) Receptor Chains or Parts Thereof that Mediate an Anti-Tumour or an Anti-Infective Response | 2019-07-11 |
20190209614 | METHODS AND COMPOSITION FOR PRODUCING AND USING IMMUNE CELLS AND STEM CELLS FOR CELL-BASED THERAPIES | 2019-07-11 |
20190209615 | T-CELL IMMUNOTHERAPY | 2019-07-11 |
20190209616 | CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF | 2019-07-11 |
20190209617 | COMPOSITIONS CONTAINING PLATELET CONTENTS | 2019-07-11 |
20190209618 | METHODS AND COMPOSITIONS FOR EXPANSION OF HEMATOPOIETIC STEM AND/OR PROGENITOR CELLS EMPLOYING A CYTOCHROME P450 1B1 (CYP1B1) INHIBITOR OR A MUSASHI-2 (MSI2) ACTIVATOR | 2019-07-11 |
20190209619 | PHARMACEUTICAL CARRIERS CONTAINING MIRNAS FOR USE IN THE TREATMENT OF FIBROTIC DISEASES CAUSED BY HYPERGLYCEMIA | 2019-07-11 |
20190209620 | CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES | 2019-07-11 |
20190209621 | MESENCHYMAL CELL-DERIVED EXOSOMES TO TREAT NEUROLOGICAL DISORDERS | 2019-07-11 |
20190209622 | SCHWANN CELL DIFFERENTIATION PROMOTING AGENT AND A PERIPHERAL NERVE REGENERATION PROMOTING AGENT | 2019-07-11 |
20190209623 | METHOD OF ACTIVATING TUMOR-INFILTRATING LYMPHOCYTES (TILS) | 2019-07-11 |
20190209624 | NANOVESICLE DERIVED FROM PROTEUS GENUS BACTERIA, AND USE THEREOF | 2019-07-11 |
20190209625 | Engineered Therapeutic Probiotic System and Method | 2019-07-11 |
20190209626 | PROBIOTIC COMPOSITIONS COMPRISING BACTERIA FROM BACTEROIDS AND FIRMICUTES PHYLA | 2019-07-11 |
20190209627 | METHODS AND GROUPS | 2019-07-11 |
20190209628 | COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER, CONTAINING LACTOBACILLUS SP. BACTERIA-DERIVED VESICLE | 2019-07-11 |
20190209629 | HIGH MOBILITY GROUP BOX I MUTANT | 2019-07-11 |
20190209630 | SANDALWOOD OIL AND ITS USES RELATED TO ORAL MUCOSITIS | 2019-07-11 |
20190209631 | Lipid Extract of Passiflora Seeds | 2019-07-11 |
20190209632 | Pharmaceutical Composition for Preventing and Treating Alpha Herpes Virus Infection, Containing, As Active Ingredient, Elaeocarpus Sylvestris Extract or Fraction Thereof | 2019-07-11 |
20190209633 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING | 2019-07-11 |
20190209634 | Herbal Nutraceutical Formulation to Reduce Oxidative Stress, Viral and Microbial Infections, and Inflammation | 2019-07-11 |
20190209635 | SUPPRESSION OF ANTIMICROBIAL PROTEIN LEVELS | 2019-07-11 |
20190209636 | MICROBES AND METHODS FOR PRODUCING THE SAME | 2019-07-11 |
20190209637 | ESSENTIAL OIL COMPOSITIONS AND APPLICATIONS UTILIZING ESSENTIAL OILS | 2019-07-11 |
20190209638 | NATURAL COMPOSITION HAVING ALPHA-GLUCOSIDASE ACTIVITY INHIBITION EFFECT AND USED FOR REGULATING THE ABSORPTION OF BLOOD GLUCOSE AND CARBOHYDRATE | 2019-07-11 |
20190209639 | Ointment for burn | 2019-07-11 |
20190209640 | NUTRITIONAL POWDER COMPOSITIONS WITH ACARICIDE ACTIVITY FOR APICULTURE AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF VARROA INFESTATIONS | 2019-07-11 |
20190209641 | METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME | 2019-07-11 |
20190209642 | METHODS OF TREATING ALZHEIMER'S DISEASE, HUNTINGTON'S DISEASE, AUTISM, AND OTHER DISORDERS | 2019-07-11 |
20190209643 | LOW-BURST POLYMERS AND METHODS TO PRODUCE POLYMER | 2019-07-11 |
20190209644 | Stable Formulations of Linaclotide | 2019-07-11 |
20190209645 | POTENTIATION OF ANTIBIOTIC ACTIVITY BY A NOVEL CATIONIC PEPTIDE, SPR741 | 2019-07-11 |
20190209646 | BACTERIAL INHIBITORS | 2019-07-11 |
20190209647 | COMPOSITIONS FOR THE TREATMENT OF INTESTINAL DISORDERS | 2019-07-11 |
20190209648 | ApoO FOR USE IN A METHOD FOR TREATING CANCER AND VARIOUS PATHOPHYSIOLOGICAL SITUATIONS | 2019-07-11 |
20190209649 | COMPOSITIONS COMPRISING ALBUMIN-FMS-LIKE TYROSINE KINASE 3 LIGAND FUSION PROTEINS AND USES THEREOF | 2019-07-11 |
20190209650 | METHOD TO IMPROVE THE EFFECTIVENESS OF ANTI-CANCER THERAPIES BY EXPOSING CANCER CELLS TO AN INFLAMMATORY STIMULUS PRIOR TO TREATMENT | 2019-07-11 |
20190209651 | Osteoarthritis Treatment With Chemokine-Loaded Alginate Microparticles | 2019-07-11 |
20190209652 | MODULATING RESPONSES TO CHECKPOINT INHIBITOR THERAPY | 2019-07-11 |
20190209653 | IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES | 2019-07-11 |
20190209654 | Biodegradable Drug Delivery Composition | 2019-07-11 |
20190209655 | Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof | 2019-07-11 |
20190209656 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | 2019-07-11 |
20190209657 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | 2019-07-11 |
20190209658 | METHODS FOR TREATING AN ANIMAL | 2019-07-11 |
20190209659 | STABLE LIQUID FIBRINOGEN | 2019-07-11 |
20190209660 | PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL | 2019-07-11 |
20190209661 | METHODS FOR TREATING TRACHEOBRONCHOMALACIA | 2019-07-11 |
20190209662 | USE OF ALKALINE PHOSPHATASE FOR PRESERVING RENAL FUNCTION | 2019-07-11 |
20190209663 | ANTIMICROBIAL AGENTS | 2019-07-11 |
20190209664 | SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF | 2019-07-11 |
20190209665 | HUMAN ASPARAGINASE LACKING GLUTAMINASE ACTIVITY | 2019-07-11 |
20190209666 | FLEXIBLE TISSUE MATRIX AND METHODS FOR JOINT REPAIR | 2019-07-11 |
20190209667 | METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS | 2019-07-11 |
20190209668 | TREATMENT OF CANINE ATOPIC DERMATITIS | 2019-07-11 |
20190209669 | PEPTIDE VACCINES AND DURVALUMAB FOR TREATING BREAST CANCER | 2019-07-11 |
20190209670 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS | 2019-07-11 |
20190209671 | Specific Chimeric Antigen Receptor T Cells Targeting to CD47, Preparation Method and Application Thereof | 2019-07-11 |
20190209672 | HYBRID HEPADNAVIRUS CORES CARRYING MULTIPLE MALARIA PARASITE EPITOPES | 2019-07-11 |
20190209673 | PCV/MYCOPLASMA HYOPNEUMONIAE VACCINE FOR USE WITH PRRSV VACCINE | 2019-07-11 |
20190209674 | COMBINATION OF NOVEL VACCINES AGAINST ZIKA VIRUS AND DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ZIKA VIRUS | 2019-07-11 |
20190209675 | MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES | 2019-07-11 |
20190209676 | Porcine Epidemic Diarrhea Preventative or Therapeutic Method, Vaccine, and Vaccine Kit | 2019-07-11 |
20190209677 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | 2019-07-11 |
20190209678 | MANUFACTURE OF SURFACTANT-CONTAINING COMPOSITIONS WITH ENHANCED STABILITY | 2019-07-11 |
20190209679 | Particulate Formulations for Enhancing Growth in Animals | 2019-07-11 |
20190209680 | TREATMENT OF ACUTE LIVER FAILURE | 2019-07-11 |
20190209681 | Anti-LPS Enriched Immunoglobulin Preparation for Use in the Treatment and/or Prophylaxis of a Pathologic Disorder | 2019-07-11 |
20190209682 | ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF | 2019-07-11 |
20190209683 | BIOPHOTONIC COMPOSITIONS, METHODS, AND KITS FOR INHIBITING AND DISRUPTING BIOFILMS | 2019-07-11 |
20190209684 | Synthetic Retinoids (in Cell Modulation) | 2019-07-11 |
20190209685 | SYNTHETIC RETINOIDS (IN CELL MODULATION) | 2019-07-11 |
20190209686 | PULSE PHOTODYNAMIC TREATMENT OF ACNE | 2019-07-11 |
20190209687 | NEUTRON CAPTURE THERAPY SYSTEM AND THERAPY PLANNING SYSTEM FOR NEUTRON CAPTURE THERAPY | 2019-07-11 |
20190209688 | Phenylephrine-Containing Liquid Formulations | 2019-07-11 |
20190209689 | ABSORPTION ENHANCERS FOR DRUG ADMINISTRATION | 2019-07-11 |
20190209690 | Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery | 2019-07-11 |
20190209691 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | 2019-07-11 |
20190209692 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | 2019-07-11 |
20190209693 | COMPOSITION COMPRISING AN ORGANIC LIQUID DILUENT AND A CELLULOSE ETHER OF VERY LOW VISCOSITY | 2019-07-11 |
20190209694 | METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS | 2019-07-11 |
20190209695 | Pharmaceutical Compositions for High-Capacity Targeted Delivery | 2019-07-11 |
20190209696 | SYNTHETIC ANTIBODY MIMETIC COMPOUNDS (SYAMS) TARGETING CANCER, ESPECIALLY PROSTATE CANCER | 2019-07-11 |
20190209697 | CELLS LABELLED WITH LIPID CONJUGATES AND METHODS OF USE THEREOF | 2019-07-11 |
20190209698 | POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY | 2019-07-11 |
20190209699 | PEGYLATED BIOACTIVE PEPTIDES AND USES THEREOF | 2019-07-11 |
20190209700 | SPIROCYCLIC INDOLONE POLYETHYLENE GLYCOL CARBONATE COMPOUND, COMPOSITION, PREPARATION METHOD AND USE THEREOF | 2019-07-11 |
20190209701 | COMBINATION THERAPY WITH A MEK INHIBITOR, A PD-1 AXIS INHIBITOR, AND A TAXANE | 2019-07-11 |
20190209702 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | 2019-07-11 |